Boston Scientific is revolutionizing the field of drug-eluting therapies with the most complete portfolio of technologies.
Watch experts deploy the Eluvia DES and Ranger DCB to treat a polystenotic calcified SFA lesion in a 75-year-old male patient.
January 18, 2017
WANT TO KNOW MORE?
Join our Drug-Eluting Technologies Community
Sign Up for Product Updates
Receive the latest news of Drug Eluting TechnologiesSIGN UP